Skip to main content
OpenTrials

Clinical trial condition

Hepatitis, Chronic

Explore clinical trials studying Hepatitis, Chronic. Study availability and eligibility vary by location and protocol.

1,281 public trials 89 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis, Chronic trial results

Completed

Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon

NCT01542788

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • SCTI Research Foundation Liver Center Coronado, California, United States
  • Kaiser Permanente Los Angeles, California, United States
  • Lightspeed Medical Los Angeles, California, United States
View all 63 locations
View Trial Details
Completed

Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection

NCT01641640

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • SCTI Research Foundation Coronado, California, United States
  • Kaiser Permanente Los Angeles, California, United States
  • Peter J. Ruane, MD, Inc. Los Angeles, California, United States
View all 56 locations
View Trial Details
Completed

Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C

NCT00495391

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • VA Palo Alto Healthcare System Palo Alto, California, United States
  • Stanford University School of Medicine Stanford, California, United States
  • Yale University Digestive Diseases New Haven, Connecticut, United States
  • University of Florida Hepatology Gainesville, Florida, United States
View Trial Details
Completed

Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis B

NCT00877760

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Ruijin Hospital Shanghai, China
  • Shanghai Public Health Center Shanghai, China
  • Zhong Shan hospital, Fu Dan University Shanghai, China
  • Amsterdam Medical Center (AMC) Amsterdam, Netherlands
View all 13 locations
View Trial Details

Related conditions